Peter Wrighton-Smith

All filings by Peter Wrighton-Smith on record concern Oxford Immunotec Global PLC. The record holds 47 filings, for trades running from 4 March 2016 to 8 March 2021.

The open-market side counts 3 purchases for €461k alongside 24 sales for €8.5M. Netting one side against the other leaves €8.0M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 share grants and 13 option exercises.

A typical purchase (the median) is worth €165k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 12 March 2021, reports a transaction of €7.4M in Oxford Immunotec Global PLC. The most recent open-market purchase was published on 12 May 2020, 2,355 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.